Ginting Binawati, Maulana Ilham, Yahya Mustanir, Saidi Nurdin, Murniana Murniana, Hasballah Kartini, Maulidna Maulidna, Rawati Siti
Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Indonesia.
Department of Pharmacology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
J Adv Pharm Technol Res. 2022 Jul-Sep;13(3):216-220. doi: 10.4103/japtr.japtr_105_22. Epub 2022 Jul 5.
is a plant species that has been popularly used to treat a broad spectrum of diseases. In efforts of tackling the increasing threat of cancers, has been studied for its anticancer potentials. Hence, through this research, we aimed to evaluate the antioxidant and antiproliferative activities of n-hexane extract from L. leaves along with its fractionation products. After the n-hexane extract has been obtained, the sample was column chromatographed using gradient elution with n-hexane:ethyl acetate solvent. All the isolation protocols produced 1 n-hexane extract and 10 different fractions (fractions 1-10). Antioxidant and antiproliferative effects of the samples were assessed based on 2,2-diphenyl-1-picrylhydrazyl and brine shrimp lethality test assay, respectively. None of the samples have a strong antioxidant level because all samples yielded IC of more than 100 ppm - the best of them was fraction 8 with IC = 113.716 ppm. On contrary, most of the samples were observed to have a potent antiproliferative effect, especially fraction 8 with LC = 2.00 ppm. Taken altogether, fraction 8 from the n-hexane extract of L. leaves is the most potential candidate for proliferative disease therapy, where further studies confirming the results are required.
是一种长期以来被广泛用于治疗多种疾病的植物物种。为应对日益增长的癌症威胁,人们对其抗癌潜力进行了研究。因此,通过本研究,我们旨在评估[植物名称]叶正己烷提取物及其分馏产物的抗氧化和抗增殖活性。获得正己烷提取物后,将样品用正己烷:乙酸乙酯溶剂梯度洗脱进行柱色谱分离。所有分离方案得到了1种正己烷提取物和10种不同的馏分(馏分1 - 10)。分别基于2,2 - 二苯基 - 1 - 苦基肼和卤虫致死试验评估样品的抗氧化和抗增殖作用。所有样品均无强抗氧化水平,因为所有样品的半数抑制浓度(IC)均超过100 ppm,其中最好的是馏分8,IC = 113.716 ppm。相反,大多数样品具有较强的抗增殖作用,尤其是馏分8,其半数致死浓度(LC) = 2.00 ppm。总体而言,[植物名称]叶正己烷提取物的馏分8是增殖性疾病治疗最具潜力的候选物,需要进一步研究以证实该结果。